Rocky Mountain Cancer Centers

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

• Rocky Mountain Cancer Centers-Aurora

  Aurora, Colorado 80012

  125 vizsgálat

• Rocky Mountain Cancer Centers-Littleton

  Littleton, Colorado 80120

  118 vizsgálat

• Rocky Mountain Cancer Centers-Thornton

  Thornton, Colorado 80260

  118 vizsgálat

• Rocky Mountain Cancer Centers-Lakewood

  Lakewood, Colorado 80228

  115 vizsgálat

• Rocky Mountain Cancer Centers - Centennial

  Centennial, Colorado 80112

  61 vizsgálat

• Rocky Mountain Cancer Centers - Swedish

  Englewood, Colorado 80113

  55 vizsgálat

• Rocky Mountain Cancer Centers-Greenwood Village

  Greenwood Village, Colorado 80111

  39 vizsgálat

• Rocky Mountain Cancer Centers

  Denver, Colorado 80218

  36 vizsgálat

• Rocky Mountain Cancer Centers

  Aurora, Colorado 80012

  21 vizsgálat

• Rocky Mountain Cancer Center

  Denver, Colorado 80218

  18 vizsgálat

• Rocky Mountain Cancer Centers,LLP

  Lone Tree, Colorado 80124

  18 vizsgálat

• Rocky Mountain Cancer Centers

  Lone Tree, Colorado 80124

  16 vizsgálat

• Rocky Mountain Cancer Centers,LLP

  Aurora, Colorado 80012

  16 vizsgálat

• Rocky Mountain Cancer Centers, LLP

  Denver, Colorado 80218

  13 vizsgálat

• Rocky Mountain Cancer Centers

  Boulder, Colorado 80304

  9 vizsgálat

• Rocky Mountain Cancer Centers

  Colorado Springs, Colorado 80907

  9 vizsgálat

• Rocky Mountain Cancer Center

  Aurora, Colorado 80012

  8 vizsgálat

• Rocky Mountain Cancer Centers

  Lakewood, Colorado 80228

  6 vizsgálat

• Rocky Mountain Cancer Centers

  Littleton, Colorado 80120-4413

  5 vizsgálat

• Rocky Mountain Cancer Centers (Williams) - USOR

  Aurora, Colorado 80012

  5 vizsgálat

• Rocky Mountain Cancer Centers - Denver Midtown

  Denver, Colorado 80218

  4 vizsgálat

• Rocky Mountain Cancer Centers

  Longmont, Colorado 80501

  3 vizsgálat

  • NCT05103358Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  • NCT03781063Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  • NCT03822468Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

• Rocky Mountain Cancer Center

  Lone Tree, Colorado 80124

  2 vizsgálat

  • NCT06396065Phase III Study of AK112 for NSCLC Patients

  • NCT03706365A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

• Rocky Mountain Cancer Center - Aurora

  Aurora, Colorado 80012

  2 vizsgálat

  • NCT05608044A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

  • NCT03235544A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

• Rocky Mountain Cancer Centers

  Pueblo, Colorado 81008

  2 vizsgálat

  • NCT05103358Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  • NCT01909453Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

• Rocky Mountain Cancer Centers

  Thornton, Colorado 80260

  2 vizsgálat

  • NCT05103358Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  • NCT04579380Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

• Rocky Mountain Cancer Centers,10107 Ridge Gate Parkway

  Lone Tree, Colorado 80124

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers,11750 West 2nd Place

  Lakewood, Colorado 80228

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers,1700 South Potomac Street

  Aurora, Colorado 80012

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers,22 West Dry Creek Circle

  Littleton, Colorado 80120

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers,4700 E. Hale Parkway

  Denver, Colorado 80220

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers,8820 Huron Street

  Thornton, Colorado 80260

  2 vizsgálat

  • NCT05382286Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  • NCT05382299Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

• Rocky Mountain Cancer Centers (Aurora) - USOR

  Aurora, Colorado 80012

  2 vizsgálat

  • NCT06524375A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Centers - Lone Tree

  Lone Tree, Colorado 80124

  2 vizsgálat

  • NCT07623200A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  • NCT04256421A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

• Rocky Mountain Cancer Centers (Williams) - USOR

  Denver, Colorado 80218

  2 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

  • NCT01909453Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

• US Oncology - Rocky Mountain Cancer Centers - Midtown

  Denver, Colorado 80218

  2 vizsgálat

  • NCT04987203Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

  • NCT03778931Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

• Duplicate_Rocky Mountain Cancer Centers - Lone Tree /ID# 215789

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT03539536Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

• Rocky Mountain Cancer Center

  Littleton, Colorado 80120

  1 vizsgálat

  • NCT06695845A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

    Contact: Clinical Trial Disclosure & Transparency

• Rocky Mountain Cancer Center, 1800 Williams Street, Suite 200

  Denver, Colorado 80124

  1 vizsgálat

  • NCT02917993An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

• Rocky Mountain Cancer Center - Denver

  Denver, Colorado 80220

  1 vizsgálat

  • NCT04294810A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

• Rocky Mountain Cancer Center - Denver

  Littleton, Colorado 80120

  1 vizsgálat

  • NCT04338269A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

• Rocky Mountain Cancer Center - Hale Parkway

  Denver, Colorado 80220

  1 vizsgálat

  • NCT05169567Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

• Rocky Mountain Cancer Center - Primary

  Denver, Colorado 80218

  1 vizsgálat

  • NCT07011576A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

    Contact: Sarah Cannon Sarah Cannon Development Innovations, LLC

• Rocky Mountain Cancer Centers / Aurora, CO

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT04704154A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

• Rocky Mountain Cancer Centers - Aurora /ID# 252237

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT05753501Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

• Rocky Mountain Cancer Centers - Aurora /ID# 267549

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT06428019A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

• Rocky Mountain Cancer Centers - Aurora /ID# 268574

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT05650632A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

• Rocky Mountain Cancer Centers - Aurora /ID# 280112

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT07525206A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

• Rocky Mountain Cancer Centers - Aurora- Site Number : 8400021

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT05405166SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

• Rocky Mountain Cancer Centers - Denver Midtwon /ID# 254163

  Denver, Colorado 80218

  1 vizsgálat

  • NCT05822752Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

• Rocky Mountain Cancer Centers (Denver) - USOR

  Denver, Colorado 80220

  1 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Center (Site 8010)

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT03142334Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

• Rocky Mountain Cancer Centers (Lakewood) - USOR

  Lakewood, Colorado 80228

  1 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Centers - Littleton /ID# 222562

  Littleton, Colorado 80120

  1 vizsgálat

  • NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

• Rocky Mountain Cancer Centers (Littleton) - USOR

  Littleton, Colorado 80120

  1 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Centers, LLP- Aurora

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT07549412A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

    Contact: Communication Center

• Rocky Mountain Cancer Centers, LLP - Oncology

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT05245500Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

    Contact: Robert Jotte, Site 109

• Rocky Mountain Cancer Centers, LLP (Site #0122)

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT06788990FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

    Contact: Principal Investigator

• Rocky Mountain Cancer Centers, Llp(Us Oncology Research)

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT05909904A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

• Rocky Mountain Cancer Centers - Lone Tree /ID# 272603

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT06772623Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

• Rocky Mountain Cancer Centers - Lone Tree /ID# 278320

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT06158841Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

• Rocky Mountain Cancer Centers (Lone Tree) - USOR

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Centers (RMCC)

  Denver, Colorado 80220

  1 vizsgálat

  • NCT06449222Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

• Rocky Mountain Cancer Centers (RMCC) (Site 8000)

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT06997497A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Contact: Study Coordinator

• Rocky Mountain Cancer Centers (RMCC) (Site 8001)

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT06890884A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

    Contact: Study Coordinator

• Rocky Mountain Cancer Centers (RMCC) (Site 8006)

  Denver, Colorado 80220

  1 vizsgálat

  • NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    Contact: Study Coordinator

• Rocky Mountain Cancer Centers (RMCC) (Site 8011)

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT06788912Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

• Rocky Mountain Cancer Centers (Thornton) - USOR

  Thornton, Colorado 80260

  1 vizsgálat

  • NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

• Rocky Mountain Cancer Centers - USOR

  Denver, Colorado 80218

  1 vizsgálat

  • NCT05141721A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

• Rocky Mountain Cancer Centers (Williams St)

  Denver, Colorado 80218

  1 vizsgálat

  • NCT05103358Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

• Rocky Mountain Cancer Ctr - Denver (Williams)

  Denver, Colorado 80218

  1 vizsgálat

  • NCT03148418A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

• US Oncology - Rocky Mountain Cancer Center

  Aurora, Colorado 80012

  1 vizsgálat

  • NCT04607772Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

• (USO) Rocky Mountain Cancer Centers

  Littleton, Colorado 80120-4413

  1 vizsgálat

  • NCT02649790Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

• USO - Rocky Mountain Cancer Centers

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    Contact: Robert Jotte (principal investigator)

• USOR: Rocky Mountain Cancer Centers

  Lakewood, Colorado 80228

  1 vizsgálat

  • NCT04209855A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

• USOR - Rocky Mountain Cancer Centers - Aurora

  Aurora, Colorado 80045

  1 vizsgálat

  • NCT04562389Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

• USOR - Rocky Mountain Cancer Centers - Lone Tree

  Lone Tree, Colorado 80124

  1 vizsgálat

  • NCT04613596Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    Contact: Robert Jotte, Site 007-872

• Rocky Mountain Cancer Centers - Lone Tree /ID# 252237

  Lone Tree, Colorado 80124